Study Shows Ivermectin Not Recommended for Treatment of COVID-19

February 24, 2022 by Alexa Hornbeck
Study Shows Ivermectin Not Recommended for Treatment of COVID-19

A new study released this week in JAMA Internal Medicine finds ivermectin, an antiparasitic drug, has failed to treat individuals with COVID-19.  

To conduct the open-label study, researchers enrolled high-risk patients with COVID-19 from 20 public hospitals and COVID-19 quarantine centers in Malaysia between May 31 and October 25, 2021. 

The patients were randomized to receive either oral ivermectin for five days plus standard of care, or standard of care without ivermectin for five days, which was administered during the first week of illness. The researchers found the treatment did not reduce the risk of developing severe disease compared with the standard of care. 

Among the 490 patients included in the analysis, 21.6% in the ivermectin group and 17.3% in the control group progressed to severe disease and for all secondary outcomes there were no significant differences between the groups. 

Despite these findings, which indicate that ivermectin should not be a factor in treatment decisions, researchers say the inexpensive and widely available treatment remains popular because of certain political backing.

Alexa can be reached at [email protected]

A+
a-

In The News

Health

Voting

Health

December 8, 2023
by Dan McCue
FDA Approves a CRISPR-Based Medicine to Treat Sickle Cell Disease

WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for... Read More

WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for the treatment of sickle cell disease. The new treatment, called Casgevy, was manufactured by Vertex Pharmaceuticals, of Boston, Massachusetts, and CRISPR Therapeutics, of Switzerland, using a... Read More

Chronic Fatigue Syndrome More Common Than Past Studies Suggest, CDC Says

NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have... Read More

NEW YORK (AP) — Health officials on Friday released the first nationally representative estimate of how many U.S. adults have chronic fatigue syndrome: 3.3 million. The Centers for Disease Control and Prevention's number is larger than previous studies have suggested, and is likely boosted by some... Read More

December 8, 2023
by Tom Ramstack
White House Threatens to Penalize Pharma Companies for High Prices

WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a... Read More

WASHINGTON — The Biden administration announced a plan Thursday to lower prescription drug costs in a move that takes a tough stance toward pharmaceutical companies charging high prices. If the Federal Trade Commission determines the prices are unreasonable, the new policy allows the federal government to... Read More

December 6, 2023
by Dan McCue
House Unanimously Passes Bill to Increase Mental Health Resources for Veterans’ Caregivers

WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health... Read More

WASHINGTON — The House on Monday unanimously passed the Caregiver Outreach and Program Enhancement Act, which would increase mental health resources available to caregivers of America’s veteran population. Alternately known as the COPE Act, the bipartisan legislation sponsored by Reps. Chrissy Houlahan, D-Pa., and Jen Kiggans,... Read More

December 6, 2023
by Dan McCue
HHS Unveils Next Steps to Enhance Cybersecurity of Health Care Records

WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93%... Read More

WASHINGTON — The bad guys in cyberspace want your health care records.  Between 2018 and 2022, there was a 93% increase in large breaches in the health care sector, with a 278% increase in large breaches involving ransomware, according to the Department of Health and Human... Read More

December 6, 2023
by Dan McCue
New Report Sheds Some Light on Rare Post-COVID Shot Syndrome

NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but... Read More

NEW HAVEN, Conn. — A study from the Yale School of Medicine sheds some new light on the rare, but chronic and debilitating condition some people report experiencing after getting a COVID-19 vaccination. The paper, which was posted on the preprint server medRxiv and has not... Read More

News From The Well
scroll top